12:00 AM
 | 
Oct 01, 2012
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Mitsubishi Tanabe Pharma sales and marketing update

Mitsubishi's P.T. Tanabe Indonesia subsidiary launched subcutaneous Simponi golimumab in Indonesia for rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. The pharma could not be reached for details. Mitsubishi co-markets Simponi...

Read the full 140 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >